Hemogenyx Pharmaceuticals PLC Announces Notice of AGM
Hemogenyx Pharmaceuticals PLC Announces Grant of Options and Extension of Warrant Term
Hemogenyx Pharmaceuticals PLC Announces Final Results
Hemogenyx Pharmaceuticals PLC Announces Institutional Fundraise
Hemogenyx Pharmaceuticals PLC Announces Annual IND Report with FDA
Hemogenyx Pharmaceuticals PLC Announces Tech Transfer Completion and Clinical Trial Update
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
CORRECTION FROM SOURCE: Hemogenyx Pharmaceuticals PLC Announces Issue of Equity
Hemogenyx Pharmaceuticals PLC Announces Issue of Equity
Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares
Hemogenyx Pharmaceuticals PLC - Issue of Equity
Hemogenyx Pharmaceuticals PLC Announces Publication of Prospectus
Hemogenyx shares rise after safety board backs next trial phase for CAR-T therapy
Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards
Hemogenyx Pharmaceuticals PLC Announces Clearance to Initiate Pediatric Enrolment
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
Hemogenyx Pharmaceuticals shares rise (again) as it inks agreement to commercialise CAR-T
Hemogenyx Pharmaceuticals PLC Signs Letter of Intent
Hemogenyx rises on progress in CAR-T trial
Hemogenyx Pharmaceuticals PLC Announces Third Patient Safety
Hemogenyx Pharmaceuticals PLC Announces Invitation to Participate at DCNY Summit
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes
Hemogenyx raises £570,000 and Director's Dealing
Hemogenyx gains as first adult dose cohort is completed
Hemogenyx Pharmaceuticals PLC - Third Patient Treated with HG-CT-1 CAR-T Therapy
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £250,000 and Director's Dealing
Hemogenyx Awarded Grant
Hemogenyx Pharmaceuticals PLC Announces Clearance to Proceed with Pediatric Expansion
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing
Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests
Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing
Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy
Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report
Hemogenyx Pharmaceuticals PLC Announces First Patient Safety
Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials
Hemogenyx Pharmaceuticals secures £709k of new investment
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
Hemogenyx takes major step with AML treatment - ICYMI
Hemogenyx shares jump 13% as first-in-human trial of CAR-T therapy begins
Hemogenyx begins first-human-trial for potentially ground-breaking leukaemia treatment
Hemogenyx Pharmaceuticals PLC Announces First-in-Human Treatment with HG-CT-1
Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes